HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

sangivamycin-like molecule 6

has antineoplastic activity; structure in first source

Also Known As:

SLM6 compound

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Tubercidin: 42
        sangivamycin-like molecule 6: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Tubercidin: 42
      - sangivamycin-like molecule 6: 1
  - Ribonucleosides: 49
    - Tubercidin: 42
      - sangivamycin-like molecule 6: 1

Experts

1.	Allen, Joshua E: 1 article (11/2012)
2.	Aqui, Nicole: 1 article (11/2012)
3.	Dicker, David T: 1 article (11/2012)
4.	Dolloff, Nathan G: 1 article (11/2012)
5.	El-Deiry, Wafik S: 1 article (11/2012)
6.	Malysz, Jozef: 1 article (11/2012)
7.	Talamo, Giampaolo: 1 article (11/2012)
8.	Vogl, Dan: 1 article (11/2012)

Related Diseases

1.	Multiple Myeloma 11/01/2012 - "Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9."

Related Drugs and Biologics

1.	Cyclins